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Abstract.  Inherited metabolic diseases identified currently in humans exceed 500, from which more than 
100 are inborn errors in amino acids metabolism. Phenylketonuria (PKU) and maple syrup urine diseases 
(MSUD) are autosomal recessive disorders caused by deficiency of enzymes implicated in the metabolism of 
phenylalanine (Phe) and branched chain aminoacids. PKU and MSUD lead to mental retardation unless the 
newborns are maintained on strict diet, free of Phe and, respectively of branched chain aminoacids. The early 
diagnosis of these two diseases is extremely important for the newborns life. 
 An ID-GC/MS method is proposed for the quantitation of Phe, Tyr, Leu, Val and Tyr in blood spots. 
Aminoacids are extracted from blood spots (20 µl blood) prelevated from newborns on filter paper with 
methanol:HCl and derivatized as N-trifluoroacetyl butyl esters. A Trace DSQ Thermo Finnigan quadrupole mass 
spectrometer in the EI mode coupled with a Trace GC and a capillary column Rtx-5MS was used. Two 
temperature programs were used for scan mode and SIM (selected ion monitoring) mode. The method was 
applied for control subjects and PKU patients. All the BIA positive patients have high levels of Phe (89-143 
µg/ml). The Phe/Tyr ratio was 0.60 for control samples and ranged between 1.86 and 4.63 in the PKU patients. 
The proposed ID-GC/MS method is minimum invasive, sensitive, rapid and inexpensive and allows the 
simultaneous quantitation of several aminoacids in small blood samples. This method can be used for the 
newborns screening for PKU and MSUD.  
 
INTRODUCTION 
 
Inherited metabolic diseases identified currently in humans exceed 500. More than 100 
are inborn error in amino acids metabolism. Metabolic disturbances are caused by deficiency 
of catalytic or transport protein. The symptoms of metabolic diseases are consequences of 
substrate accumulation, accumulation of normally minor metabolites produced in excess or 
deficiency of product [Clarke, 2006].  
Among other amino acidopathies, phenylketonuria (PKU) and maple syrup urine disease 
(MSUD) are severe inherited metabolic diseases. PKU is an autosomal recessive disease 
caused by deficiency of hepatic phenylalanine hydroxylase (PAH; EC 1.14.16.1). It results in 
the inability to convert phenylalanine (Phe) into tyrosine (Tyr) and the transamination of Phe 
to phenylpyruvate, which is excreted in urine. The classical form of PKU is characterized by a 
high concentration of Phe in blood and by excretion of phenylpyruvic and phenyllactic acids 
in urine. The normal concentration of phenylalanine in blood must be lower than 120 µM (2 
mg/dl). In PKU patients the Phe concentration can be several times higher, even up to 1000 
µM. In the blood of healthy patients the Phe/Tyr ratio is 0.7-0.8, while in PKU patients it 
often exceeds 3. PKU causes mental retardation unless the newborn receive a diet with low 
content in Phe, Tyr supplements, and in some cases, tetrahydrobiopterin (the cofactor of 
PAH). Maple syrup urine disease (MSUD) is an autosomal recessive disorder caused by a 
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defect in the metabolism of branched chain aminoacids (BCA): leucine (Leu), valine (Val) 
and isoleucine (Ile). The disease is associated with a high concentration of branched chain 
aminoacids in blood and urine and excretion of some of their oxo and hydroxyl derivatives.  
MSUD is associated with seizures, acidosis, severe retardation or even death. Newborns with 
MSUD are maintained on a strict diet with low level of BCA.  
Although PKU and MSUD are rare (incidence 1:13500 for PKU and 1:200.000 for 
MSUD) their effects on the newborns health are severe.  The diagnosis of PKU is based on 
quantification of Phe level in blood or urine of newborns. The most known and still applied 
method to determine Phe is the Bacterial Inhibition Assay (BIA), proposed by Guthrie. It is a 
semiquantitative and rapid method but can give false positive results. Several 
chromatographic [Kitagawa et al, 1975; Amin et al, 1995; Reilly et al, 1998; Chace et al., 
1998; Paez et al, 2000; Zytkovicz et al, 2001; Deng et al; 2002; Deng et al, 2005], 
spectroscopic [Schulze et al, 2002; Constantinou et al, 2005; Pan et al, 2007] or molecular 
methods [Chuang et al, 1995] were developed in the last decades, and were or are currently 
applied for newborns screening for PKU and MSUD in developed countries.  
The aim of this study was to develop a minimum invasive, sensitive, rapid and 
inexpensive method for the simultaneous quantitation of several aminoacids in small blood 
samples by ID-GC/MS. 
 
MATERIAL AND METHODS 
 
The blood samples were obtained as spots from patients from the Pediatric Clinic III 
Cluj-Napoca. Small discs were punched out from blood spots and placed in a vial. 
Aminoacids were extracted with methanol/HCl 0.1%. An aliquot of the extract was placed in 
a vial and the internal standard 15N-glycine was added. Amino acids were derivatized as 
trifluoroacetyl butyl ester derivatives in two steps:  butanol:acetyl chloride, 4:1, (v/v) for 30 
min at 100 °C (esterification of carboxyl group) and then with trifluoacetic anhydride at 100 
°C for 30 min (derivatization of amino group). The excess reagent was removed under 
nitrogen at ice temperature, ethyl acetate was added and the samples were subjected to 
GC/MS analysis.  
A Trace DSQ Thermo Finnigan quadrupole mass spectrometer in the EI mode coupled 
with a Trace GC was used with a capillary column Rtx-5MS (30 m x 0.25 mm, 0.25µm film 
thickness). The temperature programs were: (1) from 50oC, 1 min, 6oC/min at 100oC, 4oC/min 
to 200oC, 20oC/min to 300oC, (3min) in the scan mode and (2) from 50oC (1 min), then 20 o 
C/min to 310oC, in the selected ion monitoring mode (SIM). The carrier gas was helium with 
a flow rate of 1 ml/min. The parameters were: transfer line temperature 250oC, injector 
temperature 200 oC; ion source temperature 250 oC; splitter: 10:1. Electron energy was 70eV 
and emission current, 100µA. For the SIM mode the regression curves were obtained by 
injecting standard solutions containing amino acids in concentrations of 1 to 40µg/ml.   
 
RESULTS AND DISCUSSION 
 
Derivatization of aminoacids as N-trifluoroacetyl butyl esters allows a good separation 
of blood aminoacids, in both temperature programs (Fig. 1). For the SIM mode analysis, for 
each aminoacids some representative ions were selected: m/z 168 for Val, m/z 182 for Leu, 
m/z 166 for Pro, m/z 91 and 148 for Phe, m/z 203, 260 and 316 for Tyr. 
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Five standard aminoacids were used for calibration curves, by plotting the integration 
area of selected ion (y) versus concentration (x). The method showed good linearity, as can be 
seen in Table 1.  
 
Table 1. Regression curves equations for selected aminoacids 
 
AMINOACID EQUATION R2 
Leucine y = 0.1073x + 0.2082 0.9920 
Valine y = 0.3632x + 0.3284 0.9888 
Phenylalanine y = 0.3428x + 0.9374 0.9763 
Tyrosine y = 0.5117x + 0.1273 0.9509 
Proline y = 0.3646x + 0.9485 0.9842 
 
 
 
 
 
 
Fig. 1. TIC chromatogram of blood  aminoacids (up) and mass spectra of Phe-TFA-N-butylester 
 
 Blood samples from 6 healthy subjects (control) and 5 PKU patients, positive for BIA 
test, were analyzed as described before, using the second temperature program, in SIM mode. 
The quantitative results are presented in Table 2. Control samples are characterized by low 
levels of Phe, with a mean of 1.32 µg/ml. All the BIA positive patients have high levels of 
Phe (89-143 µg/ml), which exceeds the normal values.  
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Table 2. Aminoacids concentration in blood samples from healthy and PKU patients. 
Control  
( 15 samples) 
PKU patients 
AA Mean 
(µg/ml) 
1 
(µg/ml) 
2 
(µg/ml) 
3 
(µg/ml) 
4 
(µg/ml) 
5 
(µg/ml) 
Val 4.05 ± 0.28 22.16 21.51 22.27 23.22 21.47 
Leu 3.39 ± 0.17 33.16 19.92 22.96 25.84 16.97 
Pro 3.40 ± 0.27 65.66 31.42 37.76 25.64 19.85 
Phe 1.32 ± 0.14 131.30 119.34 93.18 142.68 89.75 
Tyr 2.19 ± 0.11 57.20 33.53 50.02 35.91 19.40 
Phe/Tyr 0.60 2.30 3.56 1.86 3.97 4.63 
 
 
 
 
Fig. 2a and 2b. Chromatogram of blood aminoacids of a PKU subject before and after 
treatment (tr Phe = 9.70 min, tr Tyr = 11.28 min) 
An important characteristic of aminoacids profile in PKU patients is the Phe/Tyr ratio. 
In healthy subjects an important amount of Phe is converted by hepatic PAH into Tyr and the 
Phe/Tyr ratio is lower than 1. In PKU patients, due to the deficiency of PAH, the conversion 
of Phe to Tyr can not occur or, in mild forms of the disease, occur with a low rate. In these 
cases Phe accumulates in blood, and the Phe/Tyr ratio become higher than 1. The value of 
Phe/Tyr ratio has a mean of 0.60 for control samples and ranged between 1.86 and 4.63 in the 
PKU patients. The calculation of Phe/Tyr ration is useful to discriminate between PKU and 
hyperphenylalaninemia or transient increases of Phe in newborns. No MSUD patients could 
be identified in the screened blood samples. However, the method can be simultaneously 
applied for PKU and MSUD, by measuring the concentration of branched chain aminoacids 
and the ratio between aliphatic and aromatic aminoacids. In MSUD patients this ratio is 
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higher than 2 [Deng et al, 2002]. The method is also suitable to monitor the effectiveness of 
PKU or MSUD treatment (Fig. 2). 
 
CONCLUSIONS 
 
The ID-GC/MS method is suitable for quantitation of aminoacids in small blood 
samples  
The method is minimum-invasive, rapid, sensitive and inexpensive and can be applied 
on a large number of samples 
ID-GC/MS method is an useful tool for simultaneous diagnosis of inborn errors of 
aminoacids metabolism - PKU and MSUD  
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